International Scholarly Research Notices / 2013 / Article / Tab 2

Research Article

Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients

Table 2

Comparison of the efficacy of statins for all doses (10 mg, 20 mg, and 40 mg).

Ator 
10 mg
Ator 
20 mg
Ator 
40 mg
Ros 
10 mg
Ros 
20 mg
Prav 
20 mg
Prav 
40 mg

% reduction LDL−18.29−19.84−22.81−29.03−29.3−20.27−10.6
% reduction TG−21.05−19.95ξ−21.56−25.1ξ−16.72−12.63−13.5
% reduction total cholesterol−16.65−13.95−17.51−22.42−26.18−15.91−15.91
% increase HDL−7.21−5.56−6.49ξ−6.64−4.0−5.88−9.97
(%) patients meeting *European LDL-C goals after 2 years60.044.050.056.058.048.032.0
(%) total cholesterol < 4 mmol/L after 2 years40.032.019.638.044.030.024.5
(%) patients TG < 1.7 mmol/L after 2 years64.056.039.258.054.050.055.1
(% ) patients HDL > 1 mmol/L after 2 years70.074.068.666.065.368.074.0

LDL-C < 2.5 mmol/L (100 mg/dL) for patients with CVD and/or type 2 diabetes.
value ≤ 0.001, value ≤ 0.01, and value ≤ 0.05.